当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activation.
Theranostics ( IF 12.4 ) Pub Date : 2020-01-01 , DOI: 10.7150/thno.35045
Oriana Lo Re 1, 2 , Tommaso Mazza 3 , Sebastiano Giallongo 1, 2 , Paola Sanna 1 , Francesca Rappa 4 , Tu Vinh Luong 5 , Giovanni Li Volti 6 , Adela Drovakova 7, 8 , Tania Roskams 9 , Matthias Van Haele 9 , Emmanuel Tsochatzis 10 , Manlio Vinciguerra 1, 10
Affiliation  

Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear.

Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses.

Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4+/CD25+/FoxP3+ T cells (Tregs).

Conclusions: Loss of macroH2A1 in HCC cells drives cancer stem-cell propagation and evasion from immune surveillance.



中文翻译:

肝细胞癌细胞中组蛋白macroH2A1的缺失促进旁分泌介导的化学抗性和CD4 + CD25 + FoxP3 +调节性T细胞活化。

原理:组蛋白macroH2A1的丢失会诱导肝细胞癌(HCC)中的癌干细胞(CSCs)样细胞的出现。CSC如何与肿瘤微环境和适应性免疫系统相互作用尚不清楚。

方法:我们筛选了侵袭性人类HCC中的macroH2A1和CD44 CSC标志物表达。我们还敲低了肝癌细胞中的(KD)macroH2A1,并进行了整合的转录组和分泌组分析。

结果:与对照组织相比,人类HCC显示出低macroH2A1和高CD44表达。MacroH2A1 KD CSC样细胞将其化学抗性从旁环转移到亲本HCC细胞。MacroH2A1 KD条件培养基经转录重新编程的HCC亲本细胞激活了调节性CD4 + / CD25 + / FoxP3 + T细胞(Tregs)。

结论: HCC细胞中macroH2A1的丢失驱动了癌症干细胞的增殖和逃避免疫监测。

更新日期:2020-01-01
down
wechat
bug